Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neuroleptics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neurolepticsmarket, defines the market attractiveness level of Neuroleptics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neuroleptics industry, describes the types of Neuroleptics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neuroleptics market and the development prospects and opportunities of Neuroleptics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neuroleptics market in Chapter 13.
By Player:
Pfizer
GSK
AstraZeneca
Eli Lilly & Co
Johnson & Johnson
Allergan
Bristol-Myers Squibb
By Type:
First Generation
Second Generation
Third Generation
By End-User:
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neuroleptics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neuroleptics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neuroleptics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neuroleptics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neuroleptics Market Analysis and Outlook to 2022
-
7.1 Global Neuroleptics Consumption (2017-2022)
-
7.2 United States Neuroleptics Consumption (2017-2022)
-
7.3 Europe Neuroleptics Consumption (2017-2022)
-
7.4 China Neuroleptics Consumption (2017-2022)
-
7.5 Japan Neuroleptics Consumption (2017-2022)
-
7.6 India Neuroleptics Consumption (2017-2022)
-
7.7 South Korea Neuroleptics Consumption (2017-2022)
8 Region and Country-wise Neuroleptics Market Analysis and Outlook to 2028
-
8.1 Global Neuroleptics Consumption Forecast (2022-2028)
-
8.2 United States Neuroleptics Consumption Forecast (2022-2028)
-
8.3 Europe Neuroleptics Consumption Forecast (2022-2028)
-
8.4 China Neuroleptics Consumption Forecast (2022-2028)
-
8.5 Japan Neuroleptics Consumption Forecast (2022-2028)
-
8.6 India Neuroleptics Consumption Forecast (2022-2028)
-
8.7 South Korea Neuroleptics Consumption Forecast (2022-2028)
9 Global Neuroleptics Market Outlook by Types and Applications to 2022
-
9.1 Global Neuroleptics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global First Generation Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Second Generation Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Third Generation Consumption and Growth Rate (2017-2022)
-
9.2 Global Neuroleptics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Schizophrenia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Bipolar Disorder Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Unipolar Depression Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Dementia Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Neuroleptics Market Outlook by Types and Applications to 2028
-
10.1 Global Neuroleptics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global First Generation Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Second Generation Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Third Generation Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neuroleptics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Schizophrenia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Bipolar Disorder Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Unipolar Depression Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Dementia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Neuroleptics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neuroleptics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neuroleptics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neuroleptics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neuroleptics Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Neuroleptics Product and Service
-
14.2 GSK
-
14.2.1 GSK Company Details
-
14.2.2 GSK Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GSK Neuroleptics Product and Service
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Details
-
14.3.2 AstraZeneca Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca Neuroleptics Product and Service
-
14.4 Eli Lilly & Co
-
14.4.1 Eli Lilly & Co Company Details
-
14.4.2 Eli Lilly & Co Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli Lilly & Co Neuroleptics Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Neuroleptics Product and Service
-
14.6 Allergan
-
14.6.1 Allergan Company Details
-
14.6.2 Allergan Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Allergan Neuroleptics Product and Service
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Details
-
14.7.2 Bristol-Myers Squibb Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Neuroleptics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neuroleptics
-
Figure Neuroleptics Picture
-
Table Global Neuroleptics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuroleptics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuroleptics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neuroleptics Consumption by Country (2017-2022)
-
Figure United States Neuroleptics Consumption and Growth Rate (2017-2022)
-
Table Europe Neuroleptics Consumption and Growth Rate (2017-2022)
-
Figure China Neuroleptics Consumption and Growth Rate (2017-2022)
-
Figure Japan Neuroleptics Consumption and Growth Rate (2017-2022)
-
Figure India Neuroleptics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neuroleptics Consumption and Growth Rate (2017-2022)
-
Figure Global Neuroleptics Consumption Forecast by Country (2022-2028)
-
Figure United States Neuroleptics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neuroleptics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neuroleptics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neuroleptics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neuroleptics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neuroleptics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global First Generation Consumption and Growth Rate (2017-2022)
-
Figure Global Second Generation Consumption and Growth Rate (2017-2022)
-
Figure Global Third Generation Consumption and Growth Rate (2017-2022)
-
Figure Global Schizophrenia Consumption and Growth Rate (2017-2022)
-
Figure Global Bipolar Disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Unipolar Depression Consumption and Growth Rate (2017-2022)
-
Figure Global Dementia Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global First Generation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Second Generation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Third Generation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Schizophrenia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bipolar Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Unipolar Depression Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dementia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neuroleptics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neuroleptics Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Neuroleptics Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Neuroleptics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Neuroleptics Product and Service
-
Table Eli Lilly & Co (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly & Co Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly & Co Neuroleptics Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Neuroleptics Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Neuroleptics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Neuroleptics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Neuroleptics Product and Service
-
